Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Clin Cancer Res. 2018 Feb 2;24(15):3681–3691. doi: 10.1158/1078-0432.CCR-17-2259

Figure 3. BQ323636.1 protein was more stable than NCOR2.

Figure 3

BQ323636.1 protein did not accumulate following MG132 treatment but NCOR2 did in A) MCF-7 and B) ZR-75 cells. 5µM of MG132 was employed. (C) BQ323636.1 degraded slower than NCOR2 and had a longer half-life in the cell. Band intensities were quantified by ImageJ and normalized against intensities of 0h. Data was expressed as mean ± s.d from three independent experiments. *, p<0.05. Statistical significance was determined by student T-Test.